Patients with heart failure with reduced ejection fraction (HFrEF) frequently have coexisting chronic kidney disease (CKD). Although angiotensin receptor–neprilysin inhibitors (ARNi) improve cardiovascular outcomes in HFrEF, evidence in advanced CKD is limited, particularly regarding progression to dialysis....
C. Hsu, T. N. K. N. Truong, Ching-Lin Hung· European Heart Journal· 0 citations
OBJECTIVE
Aortic aneurysm (AA) is a potentially life threatening condition that often remains asymptomatic for prolonged periods. Although type 2 diabetes mellitus (T2DM) increases cardiovascular risk, epidemiological studies have paradoxically reported a lower incidence of AA in patients with T2DM. Antidiabetic therap...
Y. Lu, Yu-Hsuan Joni Shao, C. Hsu et al.· European Journal of Vascular...· 0 citations
BACKGROUND
Guideline-directed medical therapy (GDMT) improves outcomes in heart failure with reduced ejection fraction (HFrEF); however, variations in adherence to guidelines across hospitals and over time remain unknown. We used two Taiwanese national registries to investigate temporal and institutional differences in...
Hung-Yu Chang, Hsin-Ti Huang, Chung-Lieh Hung et al.· Journal of the Chinese Medic...· 0 citations
AIMS
Finerenone has shown benefit in chronic kidney disease, type 2 diabetes, and heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), but head-to-head data against spironolactone are limited. We compared 12-month effectiveness and safety after finerenone versus spironolactone initiation in...
Ha Trong Khang Pham, Chieh-Ju Chao, Chung-Lieh Hung et al.· ESC Heart Failure· 0 citations
Diagnostic scores for HFpEF can provide prognostic value and the proposed simple echocardiography and natriuretic peptide-based scoring systems offered superior risk discrimination.
Hung-Yu Chang, Wen-Hung Huang, Kuo-Tzu Sung et al.· Journal of the American Hear...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.